for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Drugmaker Novo Nordisk's Q3 operating profit slightly lags forecast

COPENHAGEN, Nov 1 (Reuters) - Novo Nordisk posted third-quarter operating profit a touch below expectations on Friday but nudged up its sales outlook for this year on the back of its new drugs for type 2 diabetes and obesity.

The world’s largest maker of diabetes drugs posted a quarterly operating profit of 12.9 billion Danish crowns ($1.93 billion), slightly below an average 13.1 billion crowns forecast in a Refinitiv poll of analysts.. ($1 = 6.6919 Danish crowns) (Reporting by Stine Jacobsen Editing by Shri Navaratnam)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up